Apposition-dependent induction of plasminogen activator inhibitor type 1 expression: A mechanism for balancing pericellular proteolysis during angiogenesis

Blood

Volumn 92, Issue 3, 1998, Pages 939-945

  Bacharach, Eran ^a   Itin, Ahuva ^a   Keshet, Eli ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL INVASION; CELL SURFACE; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; REGULATORY MECHANISM; STROMA;

EID: 0032147026     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.939.415k28_939_945     Document Type: Article

References (42)

1. Dano K, Andreasen PA, Grondahl HJ, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139, 1985.
2. Pollanen J, Stephens RW, Vaheri A: Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57:273, 1991
3. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/ plasmin system. J Clin Invest 88:1067, 1991
4. Pollanen J, Vaheri A, Tapiovaara H, Riley E, Bertram K, Woodrow G, Stephens RW: Prourokinase activation on the surface of human rhabdomyosarcoma cells: Localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Proc Natl Acad Sci USA 87:2230, 1990
5. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, Appella E, Blasi F: Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 9:467, 1990
6. Stephens RW, Pollanen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Ronne E, Behrendt N, Dano K, Vaheri A: Activation of pro-urokinase and plasminogen on human sarcoma cells: A proteolytic system with surface-bound reactants. J Cell Biol 108:1987, 1989
7. Estreicher A, Muhlhauser J, Carpentier JL, Orci L, Vassalli JD: The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111:783, 1990
8. Hebert CA, Baker JB: Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: Colocalization of cell surface urokinase with vinculin. J Cell Biol 106:1241, 1988
9. Pollanen J, Saksela O, Salonen EM, Andreasen P, Nielsen L, Dano K, Vaheri A: Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol 104:1085, 1987
10. Gross JL, Moscatelli D, Jaffe EA, Rifkin DB: Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol 95:974, 1982
11. Gross JL, Moscatelli D, Rifkin DB: Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 80:2623, 1993
12. Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47:487, 1986
13. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902, 1991
14. Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P: Growth factor control of extracellular proteolysis. Cell Differ Dev 32:313, 1990
15. Montesano R, Pepper MS, Vassalli JD, Orci L: Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 132:509, 1987
16. Montesano R, Pepper MS, Mohle SU, Risau W, Wagner EF, Orci L: Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62:435, 1990
17. Pepper MS, Montesano R: Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319, 1990
18. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 68:1, 1990
19. Loskutoff DJ: Regulation of PAI-1 gene expression. Fibrinolysis 5:197, 1991
20. Declerck PJ, De MM, Alessi MC, Baudner S, Paques EP, Preissner KT, Muller BG, Collen D: Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454, 1988
21. Mimuro J, Loskutoff DJ: Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin. J Biol Chem 264:936, 1989
22. Wun TC, Palmier MO, Siegel NR, Smith CE: Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin. J Biol Chem 264:7862, 1989
23. Cubellis MV, Wun TC, Blasi F: Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9:1079, 1990
24. Herz J, Clouthier DE, Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71:411, 1992
25. Schreiber AB, Kenney J, Kowalski WJ, Friesel R, Mehlman T, Maciag T: Interaction of endothelial growth factor with heparin: Characterization by receptor and antibody recognition. Proc Natl Acad Sci USA 82:6138, 1985
26. Diglio CA, Grammas P, Giacomelli F, Wiener J: Angiogenesis in rat aorta ring explant cultures. Lab Invest 60:523, 1989
27. Bacharach E, Itin A, Keshet E: In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 89:10686, 1992
28. Belin D, Vassalli JD, Combepine C, Godeau F, Nagamine Y, Reich E, Kocher HP, Duvoisin RM: Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem 148:225, 1985
29. Prendergast GC, Diamond LE, Dahl D, Cole MD: The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 10:1265, 1990
30. Levy S, Avni D, Hariharan N, Perry RP, Meyuhas O: Oligopyrimidine tract at the 5′ end of mammalian ribosomal protein mRNAs is required for their translational control. Proc Natl Acad Sci USA 88:3319, 1991
31. Bruzdzinski CJ, Riordan JM, Nordby EC, Suter SM, Gelehrter TD: Isolation and characterization of the rat plasminogen activator inhibitor-1 gene. J Biol Chem 265:2078, 1990
32. Nicosia RF, Tchao R, Leighton J: Histotypic angiogenesis in vitro: Light microscopic, ultrastructural, and radioautographic studies. In Vitro 18:538, 1982
33. Cajot JF, Bamat J, Bergonzelli GE, Kruithof EK, Medcalf RL, Testuz J, Sordat B: Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc Natl Acad Sci USA 87:6939, 1990
34. Sato Y, Rifkin DB: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109:309, 1989
35. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB: Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 111:757, 1990
36. Dennis PA, Rifkin DB: Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88:580, 1991
37. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Voss R, van-den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419, 1994
38. Salonen EM, Vaheri A, Pollanen J, Stephens R, Andreasen P, Mayer M, Dano, K, Gailit J, Ruoslahti E: Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 264:6339, 1989
39. Dong G, Schulick AH, DeYoung MB, Dichek DA: Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta 1 responsiveness in endothelium in vivo. J Biol Chem 271:29969, 1996
40. Perlmutter DH, Travis J, Punsal PI: Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency. J Clin Invest 81:1774, 1988
41. Fujii S, Lucore CL, Hopkins WE, Billadello JJ, Sobel BE: Induction of synthesis of plasminogen activator type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells. Thromb Haemost 64:412, 1990
42. Fujii S, Sobel BE: Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA. Thromb Homeost 67:233, 1992